StreetAlpha.app
Home › Stocks › UFPT

Ufp Technologies Inc (UFPT)

Consumer Cyclical
$290.85
▼ −2.70%
LAST CLOSE · NOV 20

UFP Technologies makes custom disposable medical devices and components for medical device manufacturers. It last closed at $290.85 on Nov 20, down 2.70% on the day. The next earnings report for UFPT is expected around Tue, Feb 23, 2027, after the close. For the quarter ended Sep 2026, UFPT reported EPS of $2.64 on revenue of $172.4M, with revenue up 11.6% from a year ago. Over its last 8 reports the stock moved an average of 10.3% the session after earnings. Over the last 12 months UFPT insiders bought $0 of stock on the open market and sold $13.6M, according to SEC Form 4 filings.

AI Auto Pilots
Is UFPT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold UFPT.

Key Stats

Last 12 months
Results
Revenue
$649.5M
+8.6% vs a year ago
Net income
$76.5M
+14.0% vs a year ago
EPS (diluted)
$9.79
+13.7% vs a year ago
Gross margin
28.9%
$188.0M gross profit
Valuation
Market cap
$2.3B
7.7M shares
P/E
29.7
Price over 12 month EPS
Price to sales
3.5
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$20.6M
At Sep 30
Debt
$96.0M
At Sep 30
Shareholder equity
$485.7M
Shares outstanding
7.7M
At Oct 25
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $206.3M$206.3MFY2021FY2022: $353.8M$353.8MFY2022FY2023: $400.1M$400.1MFY2023FY2024: $504.4M$504.4MFY2024FY2025: $602.8M$602.8MFY2025

From UFPT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Feb 23
Estimated date · After the close
Reported EPS
$2.64
Quarter ended Sep 2026
Year ago EPS
$2.11
+25.1% on a GAAP basis
Revenue
$172.4M
+11.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $2.10Dec '24Mar 2025: $2.21Mar '25Jun 2025: $2.21Jun '25Sep 2025: $2.11Sep '25Dec 2025: $2.25Dec '25Mar 2026: $2.24Mar '26Jun 2026: $2.68Jun '26Sep 2026: $2.64Sep '26Latest $2.64
Revenue by quarter
Dec 2024: $144.1MDec '24Mar 2025: $148.1MMar '25Jun 2025: $151.2MJun '25Sep 2025: $154.6MSep '25Dec 2025: $148.9MDec '25Mar 2026: $154.2MMar '26Jun 2026: $174.0MJun '26Sep 2026: $172.4MSep '26Latest $172.4M
How UFPT moved after its last 8 reports
Average move the session after a report ±10.3%
Nov 3, 2026After the close+17.7%
Aug 3, 2026After the close+25.2%
May 4, 2026After the close+10.3%
Feb 24, 2026After the close−0.2%
Nov 3, 2025After the close+12.1%
Aug 5, 2025Time not announced+6.4%
May 7, 2025Time not announced+0.1%
Feb 25, 2025After the close−10.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on UFPTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Technical Analysis

UFPT · as of the Nov 20 close · updated each morning
Moving sideways

The stock is 3% below its 20 day and 1% below its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 46). The nearest support is the 100 day average at $287.78, and the nearest resistance the Pivot at $294.41.

Short trendNeutral
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 5.0%/day
Key levels
$342.1152 week high+17.6%
$299.8320 day average+3.1%
$299.57Pivot R1+3.0%
$298.48Swing high (Oct 26)+2.6%
$294.7050 day average+1.3%
$294.41Pivot+1.2%
$290.85Last close
$287.78100 day average−1.1%
$287.71Swing low (Oct 21)−1.1%
$285.69Pivot S1−1.8%
$252.81200 day average−13.1%
$173.8652 week low−40.2%
Indicators
RSI (14)45.63Middle of its rangeNeutral
MACD1.41Below its signal lineBearish
Stochastic32.1Middle of its rangeNeutral
ADX (14)24.0Weak trend
Williams %R-79.7Oversold below −80, overbought above −20Neutral
CCI (20)-42.9Oversold below −100, overbought above 100Neutral
Rate of change−4.2%Change over 10 sessionsBearish
ATR (14)$14.43Typical daily range, 5.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for UFPT

What happened before

See how UFPT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow UFPT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How UFPT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for UFPTHow many large options trades hit UFPT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

UFPT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲157 buying vs 114 selling
  • ▼Held by funds -10.4 pts
  • ▲Funds holding +36
  • ●Superinvestors: 2 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding318282+12.8%
In funds' top 1075+40.0%
Held by funds112.6%123.0%−10.4 pts
New / increased49 / 10839 / 92+19.8%
Reduced / sold out100 / 1494 / 34−10.9%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See UFPT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

UFPT Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$13.6M10 sales · 6 insiders
2025-12 sold $21K2026-05 sold $635K2026-06 sold $287K2026-08 sold $12.6MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 25Marc D KozinDirectorSale7,000$304.50$2.1M
Aug 18Symeria HudsonDirectorSale298$319.11$95K
Aug 14Symeria HudsonDirectorSale1,926$324.58$625K
Aug 13Cynthia L FeldmannDirectorSale1,000$324.26$324K
Aug 10R Jeffrey BaillyExecutive ChairmanSale13,011$316.13$4.1M
Aug 7R Jeffrey BaillyExecutive ChairmanSale15,695$318.38$5.0M
Every insider buy and sale for UFPT over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See UFPT insider trades →

From SEC Form 4 filings by UFPT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether UFPT is in one of them and how their past UFPT trades turned out.

UFPT in the AI portfolios
Loading…

UFPT News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered UFPT in an article yet. Here's the latest on the wider market.

UFPT in the news

About Ufp Technologies

UFP Technologies is a contract manufacturer that designs and makes custom medical devices and components for other companies. Its products are used in minimally invasive surgery, infection prevention, wound care, wearables, and orthopedic devices, and include protective drapes, catheter parts, and packaging for implants. Many products are built to each customer's specifications. Its customers are medical device makers, and the company is based in Newburyport, Massachusetts.

Headquarters
Newburyport, MA
Founded
1963